Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts

  1. Margaret M Parker
  2. Yuan Hao
  3. Feng Guo
  4. Betty Pham
  5. Robert Chase
  6. John Platig
  7. Michael H Cho
  8. Craig P Hersh
  9. Victor J Thannickal
  10. James Crapo
  11. George Washko
  12. Scott H Randell
  13. Edwin K Silverman
  14. Raúl San José Estépar
  15. Xiaobo Zhou  Is a corresponding author
  16. Peter J Castaldi  Is a corresponding author
  1. Brigham and Women's Hospital, United States
  2. University of Alabama at Birmingham, United States
  3. National Jewish Health, United States
  4. University of North Carolina at Chapel Hill, United States

Abstract

Murine studies have linked TGF-b signaling to emphysema, and human genome-wide association studies (GWAS) studies of lung function and COPD have identified associated regions near genes in the TGF-b superfamily. However, the functional regulatory mechanisms at these loci have not been identified. We performed the largest GWAS of emphysema patterns to date, identifying ten GWAS loci including an association peak spanning a 200kb region downstream from TGFB2. Integrative analysis of publicly available eQTL, DNaseI, and chromatin conformation data identified a putative functional variant, rs1690789, that may regulate TGFB2 expression in human fibroblasts. Using chromatin conformation capture, we confirmed that the region containing rs1690789 contacts the TGFB2 promoter in fibroblasts, and CRISPR/Cas-9 targeted deletion of a ~100bp region containing rs1690789 resulted in decreased TGFB2 expression in primary human lung fibroblasts. These data provide novel mechanistic evidence linking genetic variation affecting the TGF-b pathway to emphysema in humans.

Data availability

COPDGene genetic data and RNA-seq data have been deposited in dbGaP under accession code phs000765.v3.p2. To access these data users may apply for access to the dbGaP data repository (https://www.ncbi.nlm.nih.gov/books/NBK482114/).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Margaret M Parker

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  2. Yuan Hao

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  3. Feng Guo

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  4. Betty Pham

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  5. Robert Chase

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  6. John Platig

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  7. Michael H Cho

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Michael H Cho, reports grants from GSK and personal fees from Genentech.
  8. Craig P Hersh

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Craig P Hersh, reports personal fees from Mylan, personal fees from AstraZeneca, Concert Pharmaceuticals, 23andMe, grants from Novartis, and Boehringer-Ingelheim.
  9. Victor J Thannickal

    Department of Medicine, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  10. James Crapo

    National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  11. George Washko

    Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    George Washko, reports grants and other support from Boehringer Ingelheim, PulmonX, BTG Interventional Medicine, Janssen Pharmaceuticals, and GSK.
  12. Scott H Randell

    Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    Scott H Randell, reports receiving personal fees from Amgen.
  13. Edwin K Silverman

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Edwin K Silverman, received honoraria from Novartis for Continuing Medical Education Seminars and grant and travel support from GlaxoSmithKline.
  14. Raúl San José Estépar

    Applied Chest Imaging Laboratory, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Raúl San José Estépar, reports personal fees from Boehringer Ingelheim, Eolo Medical, and Toshiba.
  15. Xiaobo Zhou

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    xiaobo.zhou@channing.harvard.edu
    Competing interests
    No competing interests declared.
  16. Peter J Castaldi

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    peter.castaldi@channing.harvard.edu
    Competing interests
    Peter J Castaldi, has received research support and consulting fees from GSK and Novartis.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9920-4713

Funding

National Heart, Lung, and Blood Institute (R01 HL124233)

  • Peter J Castaldi

National Heart, Lung, and Blood Institute (R01 HL126596)

  • Peter J Castaldi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, Parker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,763
    views
  • 197
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Margaret M Parker
  2. Yuan Hao
  3. Feng Guo
  4. Betty Pham
  5. Robert Chase
  6. John Platig
  7. Michael H Cho
  8. Craig P Hersh
  9. Victor J Thannickal
  10. James Crapo
  11. George Washko
  12. Scott H Randell
  13. Edwin K Silverman
  14. Raúl San José Estépar
  15. Xiaobo Zhou
  16. Peter J Castaldi
(2019)
Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts
eLife 8:e42720.
https://doi.org/10.7554/eLife.42720

Share this article

https://doi.org/10.7554/eLife.42720

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Daniel Hui, Scott Dudek ... Marylyn D Ritchie
    Research Article

    Apart from ancestry, personal or environmental covariates may contribute to differences in polygenic score (PGS) performance. We analyzed the effects of covariate stratification and interaction on body mass index (BMI) PGS (PGSBMI) across four cohorts of European (N = 491,111) and African (N = 21,612) ancestry. Stratifying on binary covariates and quintiles for continuous covariates, 18/62 covariates had significant and replicable R2 differences among strata. Covariates with the largest differences included age, sex, blood lipids, physical activity, and alcohol consumption, with R2 being nearly double between best- and worst-performing quintiles for certain covariates. Twenty-eight covariates had significant PGSBMI–covariate interaction effects, modifying PGSBMI effects by nearly 20% per standard deviation change. We observed overlap between covariates that had significant R2 differences among strata and interaction effects – across all covariates, their main effects on BMI were correlated with their maximum R2 differences and interaction effects (0.56 and 0.58, respectively), suggesting high-PGSBMI individuals have highest R2 and increase in PGS effect. Using quantile regression, we show the effect of PGSBMI increases as BMI itself increases, and that these differences in effects are directly related to differences in R2 when stratifying by different covariates. Given significant and replicable evidence for context-specific PGSBMI performance and effects, we investigated ways to increase model performance taking into account nonlinear effects. Machine learning models (neural networks) increased relative model R2 (mean 23%) across datasets. Finally, creating PGSBMI directly from GxAge genome-wide association studies effects increased relative R2 by 7.8%. These results demonstrate that certain covariates, especially those most associated with BMI, significantly affect both PGSBMI performance and effects across diverse cohorts and ancestries, and we provide avenues to improve model performance that consider these effects.

    1. Genetics and Genomics
    Sedigheh Delmaghani, Aziz El-Amraoui
    Insight

    The DYRK1A enzyme is a pivotal contributor to frequent and severe episodes of otitis media in Down syndrome, positioning it as a promising target for therapeutic interventions.